San Francisco36.7783° N, 119.4179° W

San Francisco

Early-Stage Collaborations Across Pharmaceutical, Medical Device and Consumer Health Sectors

If you are seeking a collaboration or investment to advance your innovative solution to improve human health, make the connection with our Johnson & Johnson Innovation team. Our regional Innovation Centers are located around the globe in the life science hot spots of Shanghai, Boston, South San Francisco and London. Each Innovation Center houses science and technology, dealmaking, and investment experts, offers a range of potential deal structures, and can contribute a variety of resources from across our company, including:

- Early-stage research funding

- Licensing and collaborations

- Financing from Seed to Series B equity investments

- Cross-sector expertise

- International markets expertise

- Pricing and reimbursement

- Preclinical, manufacturing,and clinical expertise

The teams located at the Johnson & Johnson Innovation Center are interested in building relationships with regional entrepreneurs at startup companies, universities and institutes who are developing early-stage innovations that are pre-proof of concept in humans across Pharmaceuticals, Medical Devices and Consumer sectors.

Innovation Center California(Western North America, Australia, and New Zealand)

A regional hub for collaborations throughout Western North America, Australia, and New Zealand5000 Shoreline Court South San Francisco, CA 94080 T: 650-847-4403

Rowan E. Chapman Ph.D., Head of Johnson & Johnson Innovation, California

© Johnson & Johnson Innovation, LLC 2019

March 2019

San Francisco Innovation Center California (Western NA & ANZ)

CVM

Thomas “Gus” GustafsonE: tgustaf5@its.jnj.com

IMMUNOLOGY

Jackie BensonE: jbenson4@its.jnj.com

INFECTIOUS DISEASES AND VACCINES

Nicola La MonicaE: nlamonic@its.jnj.com

ONCOLOGY

Sylvaine Cases E: scases@its.jnj.com

NEUROSCIENCE

Guy SeabrookE: gseabroo@its.jnj.com

PLATFORMS

Beth HillE: bhill4@its.jnj.com

CONSUMER

Stephanie RobertstonE: srober18@its.jnj.com

LUNG CANCER INITIATIVE

Pierre TheodoreE: ptheodor@its.jnj.com

Tatyana BeldockE: tbeldoc1@its.jnj.com

Jeff CalcagnoE: jcalcagn@its.jnj.com

Keith ChunE: kchun1@its.jnj.com

Kathy Connell (Australia & New Zealand)E: kconnel6@its.jnj.com

Emma Huang (Data Sciences)E: bhuang26@its.jnj.com

Yelda KayaE: ykaya@its.jnj.com

Han LiE: hli173@its.jnj.com

Nick Mourlas (Medical Devices)E: nmourlas@its.jnj.com

Carolyne ZimmermanE: czimme14@its.jnj.com

PHARM

Asish XavierE: axavier2@its.jnj.com

Vijay MurthyE: vmurthy2@its.jnj.com

CONSUMER

Stacy FeldE: sfeld1@its.jnj.com

MEDICAL DEVICES

Renee RyanE: rryan@its.jnj.com

Ajay Khatri E: akhatri@its.jnj.com

THERAPEUTIC AREA AND BUSINESS UNIT SCIENTIFIC LEADS

NEW VENTURES AND TRANSACTIONS JJDC VENTURE INVESTMENTS